SCHEMBL7954675

SCHEMBL7954675

O=C1Nc2ccc(Cl)cc2C(C#Cc2ccco2)(C(F)(F)F)O1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP46A1 Q9Y6A2 8/20 0.62
NR1I2 O75469 1/20 0.62
NR3C1 P04150 1/20 0.62
PGR P06401 1/20 0.62
ADRB1 P08588 1/20 0.62
ADORA3 P0DMS8 1/20 0.62
MAPT P10636 1/20 0.62
CNR1 P21554 1/20 0.62
SLC6A2 P23975 1/20 0.62
HTR2A P28223 1/20 0.62
HTR2C P28335 1/20 0.62
MAPK1 P28482 1/20 0.62
AGTR1 P30556 1/20 0.62
CCKBR P32239 1/20 0.62
PPARG P37231 1/20 0.62
OPRK1 P41145 1/20 0.62
SLC6A3 Q01959 1/20 0.62
PDE4D Q08499 1/20 0.62
PDE3A Q14432 1/20 0.62
NPSR1 Q6W5P4 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1151823 0.83 CYP46A1 (0.65) CYP46A1NR1I2NR3C1PGRADRB1
SCHEMBL1153106 0.83 CYP46A1 (0.46) CYP46A1NR1I2NR3C1PGRADRB1
SCHEMBL8083795 0.80 CYP46A1 (0.61) CYP46A1NR1I2NR3C1PGRADRB1
SCHEMBL14002297 0.78 CYP46A1 (0.67) CYP46A1NR1I2NR3C1PGRADRB1
SCHEMBL8075473 0.78 CYP46A1 (0.67) CYP46A1NR1I2NR3C1PGRADRB1
SCHEMBL14439949 0.77 CYP46A1 (0.76) CYP46A1NR1I2NR3C1PGRADRB1
SCHEMBL16160982 0.77 CYP46A1 (0.60) CYP46A1NR1I2NR3C1PGRADRB1
Efavirenz SCHEMBL3227745 0.76 CYP46A1 (1.00) CYP46A1NR1I2NR3C1PGRADRB1
Efavirenz SCHEMBL464769 0.76 CYP46A1 (1.00) CYP46A1NR1I2NR3C1PGRADRB1
Efavirenz SCHEMBL1560709 0.76 CYP46A1 (1.00) CYP46A1NR1I2NR3C1PGRADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6303780-B1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same DUPONT PHARMACEUTICALS COMPANY 2001-10-16 US disclosed
EP-0929533-A1 4,4-DISUBSTITUTED-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS AND INTERMEDIATES AND PROCESSES FOR MAKING THE SAME Du Pont Pharmaceuticals Company (US) 1999-07-21 EP disclosed
US-5874430-A COMPOUNDS AS PROTEASE, REVERSE TRANSCRIPTASE INHIBITORS FOR DIAGNOSIS DUPONT PHARMACEUTICALS COMPANY (US) 1999-02-23 US disclosed
WO-1998014436-A1 4,4-DISUBSTITUTED-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS AND INTERMEDIATES AND PROCESSES FOR MAKING THE SAME DUPONT PHARMACEUTICALS COMPANY (US) 1998-04-09 WO disclosed